Aleva Neurotherapeutics
Series CAleva Neurotherapeutics raised €16M in a Series C round in May 2016. The company is based in Lausanne, Switzerland. Investors in the round: Banexi Ventures. Data as of Nov 2026.
Amount raised
€16M
€16,363,636
Native amount
16,363,636 EUR
Stage
Series C
series c
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €16M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.